Table 4.
Subgroup analysis of LR-category based on nodule size, degree of differentiation and blood supply.
| LR-3 | LR-4 | LR-5 | LR-M | LR-TIV | Total | P | ||
|---|---|---|---|---|---|---|---|---|
| HCC | ≤3cm | – | 5 (23.8%) |
10 (47.6%) |
4 (19.0%) |
2 (9.5%) |
21 (100%) |
0.539 |
| >3cm | – | 15 (17.2%) |
43 (49.4%) |
26 (29.9%) |
5 (5.7%) |
87 (100%) |
||
| WD and MD | – | 14 (16.7%) |
45 (53.6%) |
22 (26.2%) |
3 (3.6%) |
84 (100%) |
0.134 | |
| PD and MPD | – | 0 (0.0%) |
5 (41.7%) |
6 (50.0%) |
1 (0.8%) |
12 (100%) |
||
| MLT | ≤3cm | 7 (12.3%) |
1 (1.8%) |
0 (0.0%) |
49 (86.0%) |
– | 57 (100%) |
0.037* |
| >3cm | 3 (3.7%) |
0 (0.0%) |
4 (4.9%) |
74 (91.4%) |
– | 81 (100%) |
||
| Hypo-vascular | 9 (9.3%) |
1 (1.0%) |
1 (1.0%) |
86 (88.7%) |
– | 97 (100%) |
0.091 | |
| Hyper-vascular | 1 (2.4%) |
0 (0.0%) |
3 (7.3%) |
37 (90.2%) |
– | 41 (100%) |
Data in parentheses are shown as percentages.
WD: well differentiated, MD: moderately differentiated, PD: poorly differentiated, MPD: moderately-to-poorly differentiated.
*Statistically significant.